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ABSTRACT
Background Primary ciliary dyskinesia (PCD) is a rare, usually autosomal recessive disorder of ciliary dysfunc-
tion associated with lung involvement, which has a great impact on health. There is limited information concern-
ing the aerobic fitness of children and adolescents with PCD. The aim of this study was to assess
cardiopulmonary functional capacity and its relationship with pulmonary function and physical activity (PA) levels
in patients with PCD.
Design Ten patients with PCD (age 13Æ2 ± 2Æ8 years) underwent spirometry and cardiopulmonary exercise test-
ing. PA was investigated through a questionnaire. Eight age- and body mass index-matched healthy children
were enrolled as controls. Main variables were forced expiratory volume at 1 s, peak oxygen uptake (VO2peak)
and time spent in PA.
Results Forty per cent of patients with PCD had impaired lung function as expressed by FEV1 < 85% predicted.
Only patients with impaired lung function exhibited reduced VO2peak (18Æ1 ± 7Æ9 mL ⁄ kg ⁄min). Time spent in total
daily PA was slightly lower in patients than controls, with no difference between patients with normal or reduced
lung function. In multiple regression models, male gender (b = 0Æ518, P = 0Æ018), age (b = 0Æ752, P = 0Æ035) and
time spent in vigorous PA (b = 0Æ353, P = 0Æ049) were independent predictors of aerobic fitness.
Conclusions Assessment of resting pulmonary function and cardiopulmonary functional capacity could contrib-
ute to the evaluation of pulmonary impairment in PCD. Given the benefit of physical exercise on airway clearance
and on general health and quality of life, patients with PCD should be encouraged to adopt an active lifestyle.
Keywords Cardiopulmonary exercise test, chronic lung diseases, peak oxygen uptake, physical activity, primary
ciliary dyskinesia, pulmonary function.
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Introduction
In the last decades, a relevant interest has been directed to the
assessment of aerobic fitness in chronic lung diseases, as it may
be a marker for less severe illness and a valuable tool for
predicting prognosis [1]. Peak oxygen uptake (VO2peak) during
maximal cardiopulmonary exercise testing is considered the
‘gold standard’ measure of aerobic fitness [2]. While most stud-
ies were performed in asthma or cystic fibrosis (CF), there is
very limited information concerning the aerobic fitness of chil-
dren and adolescents with primary ciliary dyskinesia (PCD,
MIM #242650). PCD is a rare (1 : 15 000–30 000 live births) and
usually autosomal recessive disease, associated with situs visce-
rum inversus (Kartagener syndrome) in nearly half the cases [3].
Impaired mucociliary clearance because of defective motility of
cilia is the hallmark of the condition [4]. Early major clinical
events are recurrent lower and upper airway infections that can
favour the development of chronic lung disease [4,5]. Although
less severe than CF, PCD has a progressively greater impact on
health in the second half of life, producing significant morbidity
and restriction of life style [6].
There is strong evidence indicating that cardiopulmonary
fitness is associated with reduced cardiovascular risk factors,
higher bone mineral density and positive general effects on
depression, anxiety, mood status and self-esteem in children
[7,8]. To date, data on cardiopulmonary functional capacity
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evaluation are lacking in patients with PCD. Therefore, this
study aims at evaluating cardiopulmonary functional capacity
and its relationship with pulmonary function tests and physical
activity (PA) levels in a group of children and adolescents with
PCD.
Patients andmethods
Patients
The study was performed between June 2007 and December
2008. At this time, 24 children with PCD (17 men; age,
7Æ6 ± 5Æ5 years; range, 0Æ1 ± 19 years) were followed at the
Department of Pediatrics, Federico II University of Naples,
Italy. Fourteen of them were excluded from the study, as they
were unable to perform spirometry and ⁄or maximal cardio-
pulmonary exercise testing for their young age (3Æ5 ± 3Æ8 years).
Therefore, the study sample included 10 subjects (seven men;
age, 13Æ2 ± 2Æ8 years).
Primary ciliary dyskinesia was suspected on the basis of
clinical features and ⁄or situs viscerum inversus [5]. Diagnosis
was confirmed by light microscopy and electron microscopic
ultrastructural analysis of cilia on a nasal brush specimen. Light
microscopy revealed dysmotility or immotility in all cases.
Clinical characteristics and electron microscopy data of the
study population are summarized in Table 1. In all patients,
ongoing treatment consisted of the following: daily airway
clearance therapy, which included chest physiotherapy and
nebulized saline prior to chest physiotherapy, and aggressive
treatment of upper and lower airway infections with antibiotic
therapy. None of them were on treatment with inhaled bron-
chodilators or corticosteroids. Exclusion criteria were acute
upper and ⁄ or lower airway infections and any concurrent
medical illness at the time of the study.
Height and weight were measured with the subjects wearing
only light clothes and no shoes. The body mass index (BMI)
was calculated (weight ⁄height2) and then transformed into BMI
standard deviation scores (BMI-SDS) according to the Italian
standards [9].
We also recruited eight age-, sex- and BMI-matched healthy
nonatopic subjects (seven male; mean age, 13Æ7 ± 3Æ1 years)
who had a normal spirometry.
Methods
Lung function assessment. Prior to cardiopulmonary
exercise, pulmonary function was determined according to
standard spirometry techniques [10]. Forced vital capacity
(FVC), forced expiratory volume at 1 s (FEV1) (expressed as %
of predicted) and FEV1 ⁄FCV (expressed as %) were obtained.
FEV1 > 85% predicted was regarded as normal.
Physical activity assessment. To obtain information about the
levels of PA, a modified version of the long International Physi-
cal Activity Questionnaire (IPAQ) for adolescents [11] and
translated into Italian according to the IPAQ committee guide-
lines (http://www.ipaq.ki.se/cultural.htm) was administered
to patients with PCD and controls. The questionnaire focuses
on four domains: (i) school-related PA, including activity dur-
ing physical education classes and breaks; (ii) transportation;
(iii) housework and (iv) leisure time. IPAQ was administered
as interview directly to the patients if age was > 15 years or
alternatively to their parents or legal guardians if age was
below 15 years. For each of the four domains, the number of
days per week and the number of PA periods per day
(> 10 min of walking, moderate activity or vigorous activity)
were recorded. Outcome measures were average minutes per
day of walking, moderate or vigorous activities; the sum of
these variables was computed to obtain minutes per day of total
PA.
Cardiopulmonary exercise test. Both patients and controls
underwent an incremental cardiopulmonary exercise test on a
bicycle ergometer (Ergoline Ergometrics 800; Bitz, Germany).
Before each test, oxygen and carbon dioxide analysers and a
flow mass sensor were calibrated by the use of available preci-
sion gas mixtures and a 3-L syringe, respectively. All equip-
ments were calibrated according to the instructions of the
manufacturer before testing. To stabilize gas measurements,
Table 1 Clinical and electron microscopy data of patients with
PCD
Clinical data Patients
Men ⁄Women 7 ⁄ 3
Situsvisceruminversus 8
Age at PCD diagnosis (years) 7Æ0 ± 5Æ3
Ultrastructural defects of cilia*
Inner and ⁄or outer dynein arms absence 6
Outer doublets disarranged 1
Few outer and inner dynein arms 2
Short inner dynein arms 1
Microtubule translocation 9 + 0 0
Basal body abnormality 1
Outer doublets extra tubules 0
Ciliary aplasia 0
*As patients can have more than one ultrastructural abnormality, totals can
exceed 100%.
PCD, primary ciliary dyskinesia.
618 ª 2011 The Authors. European Journal of Clinical Investigationª 2011 Stichting European Society for Clinical Investigation Journal Foundation
G. VALERIO ET AL. www.ejci-online.com
patients were asked to remain still on the ergometer for at least
3 min before starting exercise. After a 1-min warm-up period at
0 W workload, a ramp protocol of 15 W ⁄min was started and
continued until exhaustion. The pedalling was kept constant at
55–65 revolutions per minute. All patients were verbally
encouraged to exercise to exhaustion, as assessed using a cut-
off > 1Æ01 for the respiratory exchange ratio at peak exercise.
After maximal exercise has been reached, a cooling-down
phase consisted of 5 min of pedalling at a slow rate (< 40 revo-
lutions ⁄min) at a work rate of 0 W. A 12-lead electrocardiogram
was monitored continuously during the test, and cuff blood
pressure was manually recorded every 2 min.
Respiratory gas exchange measurements were obtained
breath by breath with the use of a computerized metabolic cart
(Vmax 29C; Sensormedics, Yorba Linda, CA, USA). Peak oxy-
gen consumption (VO2peak) was recorded as the mean value of
VO2 during the last 20 s of the test and was expressed in millili-
tres per kilogram per minute. At the end of the cardiopulmo-
nary exercise test, patients were asked to identify the primary
reason for stopping. Medical treatment administered the day of
exercise testing was recorded. VO2peak was measured and com-
pared with maximal predicted VO2 by use of a sex-, age-,
height- and weight-adjusted and protocol-specific formula out-
lined by Wassermann et al. [12,13]. The ventilation (VE) vs.
VCO2 relationship was measured by plotting minute VE
against carbon dioxide production (VCO2) obtained every 10 s
of exercise (VE ⁄VCO2 slope): both VE and VCO2 were mea-
sured in litres per minute. The VE ⁄VCO2 slope was calculated
as a linear regression function, excluding the nonlinear part of
the relationship after the onset of acidotic drive to VE as previ-
ously described [14,15].
The ethics review board of the Medical School, Federico II
University, approved the study, and informed, written consent
was obtained from the parent ⁄ legal guardian of each child and
from adult patients themselves. Reporting of the study con-
forms to the STROBE statement for observational studies and
the EQUATOR guidelines for health research [16].
Statistical analysis
Results are expressed as mean ± standard deviation unless
otherwise specified. The outcome variables were normally
distributed, and therefore the independent samples t-test or the
ANOVA test with Bonferroni post hoc analyses were used for
comparisons. Multiple linear regression analysis was
performed to determine the determinants of VO2peak. The
dependent variable was VO2peak, while the independent
variables were gender, age, BMI-SDS, FEV1% and time spent in
total or vigorous PA. P-value < 0Æ05 was considered significant.
All statistical analyses were carried out using the Statistical
Package of Social Sciences (SPSS, Chicago, IL, USA) for
Windows software program release 15Æ0.
Results
All patients performed the cardiopulmonary exercise testing
without complications and were able to complete the protocol
to volitional exhaustion. No electrocardiography abnormalities
were noted during exercise testing. Neither the patients with
PCD nor the control group had oxygen desaturation during
exercise.
Spirometry was obtained by all patients with PCD. FVC was
95Æ5 ± 11Æ8% predicted, FEV1 was 87Æ5 ± 9Æ6% predicted and the
FEV1 ⁄FCV was 77Æ1 ± 6Æ1%. FEV1 was normal (i.e. > 85% pre-
dicted) in six patients with PCD (60% of the total). Compared
with controls, patients with PCD had significantly lower
VO2peak (P < 0Æ04) and significantly higher VE ⁄VCO2 slope
(P = 0Æ005) (Table 2). Further analyses were separately per-
formed in patients with normal (FEV1 94Æ1 ± 5Æ4% predicted) or
reduced lung function (FEV1 77Æ7 ± 3Æ6% predicted) and com-
pared with controls (Table 2). VO2peak in PCD patients with
reduced lung function was significantly lower than controls,
while no difference was found when patients with preserved
lung function and controls were compared (Table 2). No differ-
ence was found among groups with regard to age or BMI-SDS.
Results of the IPAQ questionnaire showed that the time spent
in total daily PA was slightly lower in patients with PCD than
controls (P = 0Æ07), but did not differ between PCD patients
with normal or reduced lung function. When data about vigor-
ous PA were analysed, vigorous PA was reported by six of
eight (75%) controls (mean time 34Æ3 ± 25Æ9 min ⁄day) and only
by two of six (33Æ3%) PCD patients with normal lung function
(mean time 25Æ0 ± 25Æ2 min ⁄day). Among patients with PCD
and reduced lung function, none reported vigorous PA.
As shown in Table 3, after adjusting for age, gender, BMI and
FEV1% predicted, the time spent in vigorous PAwas significantly
associated to VO2peak levels in patientswith PCD (P = 0Æ049).
Discussion
The present study showed that children and adolescents with
PCD had a significantly reduced VO2peak and increased VE ⁄
VCO2 slope compared with age- and BMI-matched healthy con-
trols. When cardiopulmonary findings were stratified according
to lung function, only PCD patients with impaired lung function
exhibited impaired cardiopulmonary functional capacity.
Cardiopulmonary exercise testing is frequently used as a tool
for evaluating chronic condition in children [13,17]. It is well
known that exercise capacity, as determined by direct measure-
ment of VO2peak, exerts a major long-term influence on progno-
sis after myocardial infarction, cardiovascular revascularization
and ischaemic heart disease, playing a valuable role in risk
stratification and counselling [18,19]. To the best of our knowl-
edge, this is the first study exploring cardiopulmonary
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functional capacity as expressed by VO2peak and VE ⁄VE ⁄VCO2
slope in patients with PCD. The lack of data regarding cardio-
pulmonary functional capacity evaluation in patients with PCD
is attributable to the fact that PCD is a rare disease. Several
evidences from cross-sectional studies exploring cardiopulmo-
nary functional capacity in children with CF [20–25] essentially
conclude that lower FEV1 and reduced weight for height or lean
body mass correlate with lower peak oxygen uptake and that
peak VO2 could predict earlier mortality [1,26].
Several authors reported that higher VO2peak was signifi-
cantly correlated with survival and that neither FEV1 improved
the relationship in a multivariate model nor VO2peak was better
than FEV1 in predicting likelihood of survival over 5 years
[27,28]. More recently, a longitudinal study in patients with CF
found that VO2peak fell during the study period of 7–8 years in
70% of the patients, with a mean annual decline of
2Æ1 mL ⁄min ⁄kg [27]. Interestingly, the initial VO2peak was not
predictive of mortality, but in that series, the rate of the decline
and the final VO2peak were significant predictors. The study also
demonstrated a dramatic increase in mortality among patients
with VO2peak < 32 mL ⁄min ⁄kg, whereas none of the subjects
with VO2peak > 45 mL ⁄min ⁄kg died. Finally, the baseline and
the last values of FEV1, and the rate of its decline over time
were all significant predictors of mortality [27].
During cardiopulmonary exercise testing, a close linear rela-
tion exists between VCO2 and VE. This relationship appears
more linear and less variable than that between oxygen
consumption and minute VE [12]. The slope of the regression
line between the carbon dioxide output and the minute VE
(VE ⁄VCO2 slope) is, thus, used to describe the ventilatory
response to exercise [12]. So far, much interest has been direc-
ted towards the excessive exercise ventilatory response found
in patients with chronic heart failure that is characterized by a
steeper VE ⁄VCO2 slope [28]. The steeper slope is associated
with reduced cardiac output during exercise, increased pulmo-
nary artery and capillary wedge pressures, increased dead
space ⁄ tidal volume ratio and augmented chemoreceptor
sensitivity.
Table 2 Demographic, clinical and cardiopulmonary parameters of the study population
Controls
Patients with PCD
Whole group Preserved lung function Reduced lung function
Gender (M ⁄ F) 7 ⁄ 1 7 ⁄ 3 5 ⁄ 1 2 ⁄ 2
Age (years) 13Æ7 ± 3Æ1 13Æ2 ± 2Æ8 13Æ3 ± 2Æ4 13Æ0 ± 3Æ7
BMI (kg ⁄m2) 22Æ0 ± 2Æ5 21Æ1 ± 3Æ05 22Æ6 ± 3Æ1 18Æ9 ± 0Æ8
BMI-SDS 0Æ51 ± 0Æ71 0Æ24 ± 0Æ91 0Æ60 ± 1Æ0 )0Æ31 ± 0Æ42
HR peak (b ⁄pm) 173 ± 17 165Æ9 ± 15 172 ± 7 157 ± 21
VO2peak* (mL ⁄ kg ⁄min) 29Æ19 ± 6Æ84 22Æ0 ± 6Æ61 24Æ62 ± 4Æ52 18Æ07 ± 7Æ92
VE ⁄VCO2 slope† 26Æ68 ± 3Æ17 31Æ15 ± 2Æ61 30Æ58 ± 2Æ75 31Æ99 ± 2Æ49†
O2 pulse (mL ⁄beat) 10Æ19 ± 3Æ11 9Æ88 ± 8Æ74 7Æ55 ± 1Æ73 13Æ37 ± 14Æ04
Total PA (min ⁄day) 95Æ71 ± 55Æ98 58Æ86 ± 21Æ24 63Æ21 ± 25Æ02 52Æ32 ± 14Æ67
*Patients with PCD (whole group) vs. controls (P < 0Æ04) and reduced lung function vs. controls (P = 0Æ038).
†Patients with PCD (whole group) vs. controls (P = 0Æ005) and reduced lung function vs. controls (P = 0Æ028).
BMI-SDS, BMI standard deviation scores; PA, physical activity; PCD, primary ciliary dyskinesia; VE, ventilation.
Table 3 Multiple regression analyses
Dependent variable VO2 peak B SE b P
Model 1
Independent variables
Gender (0 = female, 1 = male) 7Æ945 1Æ800 0Æ581 0Æ012
Age 1Æ501 0Æ567 0Æ633 0Æ057
BMI-SDS 1Æ936 1Æ689 0Æ270 0Æ316
FEV1% )0Æ003 0Æ125 )0Æ004 0Æ983
Total PA 0Æ105 0Æ039 0Æ337 0Æ054
Model 2
Independent variables
Gender (0 = female, 1 = male) 7Æ090 1Æ824 0Æ518 0Æ018
Age 1Æ783 0Æ571 0Æ752 0Æ035
BMI-SDS 2Æ642 1Æ674 0Æ368 0Æ190
FEV1% )0Æ022 0Æ124 )0Æ031 0Æ869
Vigorous PA 0Æ173 0Æ062 0Æ353 0Æ049
BMI-SDS, BMI standard deviation scores; PA, physical activity.
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As our patients with PCD did not show any symptoms or
signs of cardiac disease, the higher VE ⁄VCO2 slope we
observed might be predominantly because of the altered con-
trol of VE [29]. However, the mechanisms causing an increased
ventilatory response to exercise in patients with PCD may be
multifactorial [30].
Exercise capacity is limited by the degree of severity of
pulmonary disease and also by poor nutritional status [24]. A
longitudinal study performed in CF documented that VO2peak
was correlated with FEV1 during childhood and that both FEV1
and patients’ age influenced VO2peak [31]. Nevertheless, lung
function may be early reduced or impaired in patients with
PCD [32]. In our study, FEV1 was < 85% of predicted in 40% of
the patients with PCD. However, none of them showed
severely reduced lung function nor was malnourished, as
shown by the normal range of BMI. Nevertheless, the time
spent in total PA did not significantly differ between patients
with different degree of pulmonary function impairment. Inter-
estingly, none of the PCD patients with reduced lung function
performed any kind of vigorous PA. We found that the time
spent in vigorous PA was an independent predictor of aerobic
fitness, along with male gender and age. Physiologically, small
gender differences in aerobic capacity are already evident prior
to puberty, increase significantly at puberty and persist
throughout adolescence into adulthood [33]. The progressive
increase in oxygen consumption with age, which has been
shown particularly in men, can be explained not only by physi-
cal developmental factors during puberty but also by differing
levels of PA [34]. Our results confirm that, as it occurs in
healthy children [35], vigorous PA can be an important deter-
minant of cardiopulmonary function capacity also in PCD chil-
dren with mild-to-moderate pulmonary disease. It is feasible
that patients with more severe disease have less PA because
their chronic disease makes them reluctant to be active. Unfor-
tunately, the cross-sectional design of our study does not allow
inferring any causal relationship between reduced VO2peak and
PA levels.
Subjects with chronic lung disease have been shown to bene-
fit from exercise training, mainly because it results in improve-
ments of aerobic fitness, cardiopulmonary efficiency and
mucociliary clearance, and reduces the subjective sensation of
dyspnoea [36]. Increased levels of habitual PA have been also
shown to slow the lung function decline [37] and to reduce
mortality [27]. The clinical course of PCD resembles CF,
although the severity of lung involvement appears generally
much less in PCD [30]. Also, the prognosis of PCD has been
reported as good, at least on the basis of spirometry [38,39].
However, a recent study showed that pulmonary function con-
sistently deteriorated in one-third of 74 patients with PCD,
although it remained stable over time in more than 50% of them
[40]. Therefore, prompting patients to increase daily PA could
significantly affect the severity of PCD pulmonary disease and
improve patients’ quality of life. Interestingly, it was previously
demonstrated that exercise is a more potent stimulus for bron-
chodilation than inhaled b2-agonists in children and adoles-
cents with PCD and obstructive pulmonary disease [41].
Notwithstanding the major drawback because of the small
sample size, we believe that our studymay provide valuable
information on the aerobic fitness of children and adolescents
with PCD and its relationship with lung function. Physical train-
ing at recommended levels may increase exercise tolerance in
patients with PCD, while the use of different cardiopulmonary
parameters in the evaluation of exercise tests may give more
insight into the mechanisms of reduced exercise tolerance.
Cardiopulmonary exercise testing findings may help parents,
teachers and coaches to realize that PA is feasible also in subjects
with PCD. Patients with PCD should be encouraged to adopt an
active lifestyle, given the benefit of physical exercise not only on
airway clearance but also on general health and quality of life
[42]. Finally, we believe that the combination of resting pulmo-
nary function measurements and of cardiopulmonary func-
tional capacity might be remarkably helpful for pulmonary
assessment in PCD as well as for the prescription of tailored
exercise programmes, to make PA safe for these patients.
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